KFC
AVEO

Klingenstein Fields & Co’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Klingenstein Fields & Co’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,740
Closed -$251K – 300
2013
Q4 		$251K Sell
13,740
-3,765
-22% -$75.4K 0.01% 275
2013
Q3 		$361K Sell
17,505
-4,990
-22% -$114K 0.01% 236
2013
Q2 		$562K Buy
+22,495
New +$962K 0.02% 200

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Klingenstein Fields & Co's AVEO Position: Q1 2014 in Review

Klingenstein Fields & Co sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2014, closing a stake of 13,740 shares — an estimated $251K sold.

Klingenstein Fields & Co first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $562K in Q2 2013. 68 funds tracked by Wall St. Rank hold AVEO as of Q1 2014.

  • Klingenstein Fields & Co reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Klingenstein Fields & Co sold 13,740 AVEO Pharmaceuticals, Inc. shares in Q1 2014, an estimated $251K.
  • Klingenstein Fields & Co first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Klingenstein Fields & Co's AVEO Pharmaceuticals, Inc. position peaked at $562K in Q2 2013.
  • 68 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2014.

Based on Klingenstein Fields & Co's 13F filing for Q1 2014, filed 2 May 2014.